Coloplast A/S (CLPBF)
PNK: CLPBF
· Real-Time Price · USD
98.09
-8.16 (-7.68%)
At close: May 07, 2025, 10:10 AM
Coloplast A/S Balance Sheet Statement
Financials in DKK. Fiscal
year is
October - September.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
Cash & Equivalents | 906M | 788M | 887M | 889M | 916M | 911M | 855M | 628M | 671M | 414M | 634M | 517M | 642M | 448M | 447M | 418M | 435M |
Short-Term Investments | n/a | n/a | 31M | n/a | -33M | -39M | -36M | 16M | 210M | 219M | 220M | 220M | 222M | 226M | 228M | 257M | 257M |
Long-Term Investments | n/a | n/a | 77M | 111M | 98M | 104M | 104M | 52M | -159M | -168M | -177M | -179M | -181M | -185M | -203M | -232M | -232M |
Other Long-Term Assets | 123M | 102M | 856M | n/a | n/a | n/a | n/a | 51M | 240M | 250M | 249M | 248M | 248M | 252M | 259M | 281M | 280M |
Receivables | 4.96B | n/a | 4.83B | 4.64B | 4.39B | 4.32B | 4.07B | 3.99B | 3.95B | 3.94B | 3.84B | 3.65B | 3.21B | 3.21B | 3.14B | 3.11B | 2.92B |
Inventory | 3.67B | 3.67B | 3.68B | 3.56B | 3.52B | 3.52B | 3.56B | 3.51B | 3.4B | 3.19B | 3.02B | 2.87B | 2.5B | 2.43B | 2.38B | 2.29B | 2.23B |
Other Current Assets | 420M | 5.55B | 885M | 911M | 849M | 805M | 821M | 784M | 649M | 719M | 776M | 673M | 527M | 508M | 467M | 455M | 629M |
Total Current Assets | 10.37B | 10.44B | 10.64B | 10.39B | 10.07B | 9.94B | 9.67B | 9.32B | 9.28B | 8.77B | 8.7B | 8.17B | 7.28B | 6.99B | 6.83B | 6.71B | 6.64B |
Property-Plant & Equipment | 6.75B | 6.57B | 6.43B | 6.32B | 6.07B | 5.98B | 5.79B | 5.62B | 5.4B | 5.15B | 4.92B | 4.88B | 4.42B | 4.39B | 4.23B | 4.17B | 4.04B |
Goodwill & Intangibles | 30.64B | 30.33B | 30.57B | 30.4B | 31.44B | 31.25B | 18.86B | 19.6B | 19.8B | 20.28B | 20.64B | 21.2B | 3.68B | 3.65B | 3.63B | 3.61B | 3.52B |
Total Long-Term Assets | 37.97B | 37.63B | 37.94B | 37.75B | 38.52B | 38.22B | 25.41B | 25.98B | 25.94B | 26.18B | 26.48B | 27B | 8.9B | 8.85B | 8.63B | 8.54B | 8.29B |
Total Assets | 48.34B | 48.07B | 48.58B | 48.14B | 48.59B | 48.16B | 35.09B | 35.3B | 35.22B | 34.96B | 35.19B | 35.17B | 16.19B | 15.84B | 15.46B | 15.25B | 14.93B |
Account Payables | 1.13B | 1.52B | 1.18B | 1.23B | 1.16B | 1.29B | 1.07B | 1.14B | 964M | 1.24B | 826M | 755M | 597M | 1.04B | 531M | 572M | 563M |
Deferred Revenue | n/a | n/a | 1.48B | 1.33B | n/a | 7.67B | 3.71B | n/a | n/a | n/a | n/a | n/a | 3.27B | 2.93B | 2.73B | 2.58B | 3.02B |
Short-Term Debt | 7.2B | 5.08B | 6.96B | 11.92B | 9.19B | 7.12B | 4.83B | 4.39B | 4.96B | 1.64B | 3.51B | 20.39B | 4.43B | 2.16B | 3.68B | 3.5B | 4.02B |
Other Current Liabilities | 57M | 56M | 2.58B | 2.57B | 8.33B | -6M | -4M | 3.69B | 4.34B | 4.24B | 4.08B | 3.45B | -9M | -7M | -11M | -9M | -6M |
Total Current Liabilities | 12.77B | 10.2B | 12.46B | 17.3B | 18.92B | 16.31B | 9.84B | 9.43B | 10.48B | 7.34B | 8.63B | 24.81B | 8.48B | 6.31B | 7.12B | 6.82B | 7.78B |
Long-Term Debt | 16.56B | 16.56B | 11.56B | 11.56B | 11.55B | 11.56B | 16.39B | 16.39B | 16.36B | 16.36B | 16.37B | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 500M | 155M | 7.28B | 2.29B | 2.34B | 2.13B | 1.45B | 1.79B | 1.81B | 2.47B | 2.4B | 2.6B | 676M | 673M | 641M | 649M | 639M |
Total Long-Term Liabilities | 20.11B | 19.93B | 19.59B | 14.63B | 14.55B | 14.55B | 18.76B | 18.84B | 18.83B | 19.33B | 19.27B | 3.09B | 1.29B | 1.36B | 1.42B | 1.49B | 1.37B |
Total Liabilities | 32.88B | 30.13B | 32.06B | 31.94B | 33.47B | 30.86B | 28.6B | 28.27B | 29.32B | 26.66B | 27.91B | 27.9B | 9.77B | 7.67B | 8.53B | 8.31B | 9.16B |
Total Debt | 24.76B | 22.63B | 19.52B | 24.51B | 21.63B | 19.57B | 22.11B | 21.65B | 22.19B | 18.71B | 20.59B | 21.08B | 5.04B | 2.79B | 4.28B | 4.13B | 4.67B |
Common Stock | 228M | 228M | 228M | 228M | 228M | 228M | 216M | 216M | 216M | 216M | 216M | 216M | 216M | 216M | 216M | 216M | 216M |
Retained Earnings | 16.52B | 15.39B | 17.62B | 17.45B | 15.94B | 14.63B | 7.88B | 6.57B | 6.45B | 5.39B | 7.43B | 6.18B | 6.67B | 5.41B | 7.11B | 6.08B | 5.88B |
Comprehensive Income | n/a | n/a | n/a | -1.48B | -1.04B | -1.16B | -1.6B | -816M | -762M | -495M | -370M | -187M | -465M | -433M | -400M | 216M | -322M |
Shareholders Equity | 15.46B | 17.94B | 16.52B | 16.2B | 15.13B | 17.3B | 6.49B | 7.03B | 5.91B | 8.29B | 7.28B | 7.27B | 6.42B | 8.17B | 6.93B | 6.94B | 5.77B |
Total Investments | 95M | 74M | 108M | 111M | 65M | 65M | 68M | 68M | 51M | 51M | 43M | 41M | 41M | 41M | 25M | 25M | 25M |